Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018;14(3):304-308.
doi: 10.5114/aic.2018.78336. Epub 2018 Sep 21.

Bail-out use of the Amplatzer Septal Occluder for treatment of acute iatrogenic leaflet perforation during the MitraClip procedure in a patient with functional mitral regurgitation

Adrian Kłapyta  1 , Jerzy Pręgowski  2 , Zbigniew Chmielak  2 , Piotr Szymański  3 , Adam Witkowski  2 , Marcin Demkow  4
Affiliations

Bail-out use of the Amplatzer Septal Occluder for treatment of acute iatrogenic leaflet perforation during the MitraClip procedure in a patient with functional mitral regurgitation

Adrian Kłapyta et al. Postepy Kardiol Interwencyjnej. 2018.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
A – Baseline TEE documenting significant mitral regurgitation. Bicommissural view. B – TEE images after implantation of the first MitraClip. The residual MR is still present, bicommissural and LVOT view and in the 3D TEE reconstruction – the MR jet visible in the lateral part of the double orifice of the mitral valve. C – TEE images of iatrogenic perforation of the anterior leaflet. I – bicommissural. II – bicommissural view with color Doppler imaging of significant MR jet. III – 3D reconstruction perforation of the anterior leaflet
Figure 2
Figure 2
A – TEE images after implantation of the Amplatzer septal occluder (11 mm) into the lateral orifice of the mitral valve. I – bicommissural view, II – LVOT view. B – Angiographic image of the final effect of the procedure: two MitraClips and ASO device implanted laterally
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28:1358–65. - PubMed
    1. Nickenig G, Estevez-Loureiro R, Franzen O, et al. Transcatheter Valve Treatment Sentinel Registry Investigators of the EURObservational Research Programme of the European Society of Cardiology. Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry. J Am Coll Cardiol. 2014;64:875–84. - PubMed
    1. Kubo S, Cox JM, Mizutani Y, et al. Transcatheter procedure for residual mitral regurgitation after MitraClip implantation using Amplatzer Duct Occluder II. JACC Cardiovasc Interv. 2016;9:1280–8. - PubMed
    1. Taramasso M, Zuber M, Gruner C, et al. First-in-man report of residual “intra-clip” regurgitation between two MitraClips treated by Amplatzer Vascular Plug II. EuroIntervention. 2016;11:1537–40. - PubMed
    1. Ellis JT, Wick TM, Yoganathan AP. Prosthesis-induced hemolysis: mechanisms and quantification of shear stress. J Heart Valve Dis. 1998;7:376–86. - PubMed